Voice symptoms in patients with autoimmune disease: A cross-sectional epidemiological study

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 6, 2012, Pages 1108-1113

  Liu, Zi Wei ^a   Masterson, Liam M ^a   Srouji, Ibrahim A ^a   Musonda, Patrick ^b   Scott, David G I ^c  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Autoimmune diseases; Cross sectional survey; Depression; Disease modifying antirheumatic drugs; Laryngopharyngeal reflux; Voice disorders; Voice quality; Xerostomia

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

ADULT; ANXIETY; ARTICLE; AUTOIMMUNE DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; DYSPHONIA; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREVALENCE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK FACTOR; SPONDYLARTHRITIS; XEROSTOMIA; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPONDYLOSIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, SPINE; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VOICE DISORDERS; XEROSTOMIA;

EID: 84872683968     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812459024     Document Type: Article

References (28)

1. Snow JB, Ballenger JJ. Ballenger's Otorhinolaryngology Head and Neck Surgery. 16th ed. Ontario, Canada: BC Decker; 2003:1118-1126.
2. Schwartz SR, Cohen SM, Dailey SH, et al. Clinical practice guideline: hoarseness (dysphonia). Otolaryngol Head Neck Surg. 2009;141:S1-S31.
3. Roy N, Merrill RM, Gray SD, Smith EM. Voice disorders in the general population: prevalence, risk factors, and occupational impact. Laryngoscope. 2005;115:1988-1995.
4. Best SR, Fakhry C. The prevalence, diagnosis, and management of voice disorders in a National Ambulatory Medical Care Survey (NAMCS) cohort. Laryngoscope. 2011;121:150-157.
5. Hannaford PC, Simpson JA, Bisset AF, Davis A, McKerrow W, Mills R. The prevalence of ear, nose and throat problems in the community: results from a national cross-sectional postal survey in Scotland. Fam Pract. 2005;22:227-233.
6. Merrill RM, Anderson AE, Sloan A. Quality of life indicators according to voice disorders and voice-related conditions. Laryngoscope. 2011;121:2004-2010.
7. Morzaria S, Damrose EJ. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia. J Voice. 2012;26(3):378-380.
8. Li H, Huang Z, Hu R, Zhang L, Xu W. Study on the simplified Chinese version of the Voice Handicap Index. J Voice. 2012;26(3):365-371.
9. Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and validation of the Voice Handicap Index-10. Laryngoscope. 2004;114:1549-1556.
10. Arffa RE, Krishna P, Gartner-Schmidt J, Rosen CA. Normative values for the Voice Handicap Index-10. J Voice. 2012;26(4):462-465.
11. Lin CC, Wang YY, Wang KL, et al. Association of heartburn and laryngopharyngeal symptoms with endoscopic reflux esophagitis, smoking, and drinking. Otolaryngol Head Neck Surg. 2009;141:264-271.
12. Gupta R, Sataloff RT. Laryngopharyngeal reflux: current concepts and questions. Curr Opin Otolaryngol Head Neck Surg. 2009;17:143-148.
13. Speyer R, Speyer I, Heijnen MA. Prevalence and relative risk of dysphonia in rheumatoid arthritis. J Voice. 2008;22:232- 237.
14. Sanz L, Sistiaga JA, Lara AJ, Cuende E, García-Alcántara F, Rivera T. The prevalence of dysphonia, its association with immunomediated diseases and correlation with biochemical markers. J Voice. 2012;26(2):148-153.
15. Joint Formulary Committee. Section 10.1.3. British National Formulary. 62nd ed. London: BMJ Group and Pharmaceutical Press; 2011.
16. Aliko A, Alushi A, Tafaj A, Lela F. Oral mucosa involvement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. Int Dent J. 2010;60:353-358.
17. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. http://www.R-project.org
18. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2:119-125.
19. Symmons D, Turner G, Webb R, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology. 2002;41:793-800.
20. Schwemmle C, Kreipe HH, Witte T, Ptok M. Bamboo nodes associated with mixed connective tissue disease as a cause of hoarseness [published online November 16, 2011]. Rheumatol Int.
21. Berjawi G, Uthman I, Mahfoud L, et al. Cricothyroid joint abnormalities in patients with rheumatoid arthritis. J Voice. 2010;24:732-737.
22. Ruiz Allec LD, Hernández López X, Arreguín Porras JB, Velasco Ramos R, Pacheco del Valle JC, Pérez García AI. Alterations in voice, speech and swallowing in patients with Sjögren's syndrome. Acta Otorrinolaringol Esp. 2011;62:255- 264.
23. Ozcan KM, Bahar S, Ozcan I, et al. Laryngeal involvement in systemic lupus erythematosus: report of two cases. J Clin Rheumatol. 2007;13:278-279.
24. Fisher BA, Dolan K, Hastings L, McClinton C, Taylor PC. Prevalence of subjective voice impairment in rheumatoid arthritis. Clin Rheumatol. 2008;27:1441-1443.
25. Baczyk G, Samborski P, Pieścikowska J, Kmieciak M, Walkowiak I. Comparison functioning and quality of life of patients with osteoarthritis and rheumatoid arthritis. Adv Med Sci. 2007;52(suppl 1):55-59.
26. Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis. 2004;63:723-729.
27. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med. 1998;157(5, pt 1):1658-1665.
28. Turesson C, O'Fallon W, Crowson C, Gabriel S, Matteson E. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62:722-727.